The new report "Global Topical Drug Delivery Market Will Reach USD 205.1 Billion by 2024".
The new report “Global Topical Drug Delivery Market” is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Global Topical Drug Delivery Market: Segmentation
Global Topical Drug Delivery Market, By Product Type (Topical Drug Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World)
Drivers included Topical Drug Delivery Market:
Some of the major factors driving the topical drug delivery market are ability to deliver drug at the desired site, inter-and intra-patient variations, without fluctuations in drug levels, an enhanced suitability for self-medication and improved compliance. increasing aging population, growing prevalence of skin related ailments and rising prevalence of chronic diseases, also new and better technologies for topical drug delivery is expected to boost the growth of this market are the major factors driving the growth of the injectable drug delivery market.
Rising Cases of Acute and Chronic Diseases
The prevalence of diseases and conditions such as infections which includes bacterial infection and fungal infections, inflammations, pain management, acne, sun burns, psoriasis, dermatitis, skin allergy, skin cancer, diabetes, and many others has increased considerably over a period of time.
Rising Aging Population
With the increasing age, the cases of acute and chronic diseases are rising. Older population is more prone to diseases such as diabetes, allergy, arthritis, infections, and dermatitis.
Technological Advancements and Innovations
With the rising prevalence of acute and chronic diseases it has become important for the drug and device manufacturers to develop advanced technologies that will provide more effective treatment for the diseases. In the few years, many developments took place for the topical drug delivery due to the rapid absorption of drugs.
Approval of New Drugs
With the increasing demand for the treatment of diseases using painless and non-invasive method the demand for topical drug delivery is increasing.
Better Opportunity in Pharmerging Markets
According to Data Bridge Market Research analysts, Japan, Europe and North America are expected to account for around 73% of total global pharmaceutical market, while the rest of the world only own 27% of the market.
Major Key Players Included in Topical Drug Delivery Market:
The major players in the topical drug delivery prescription drugs are
- Galderma Pharma, S.A.,
- Allergen Plc. Kaken Pharmaceuticals, Co., Ltd,
- Bayer AG,
- Hisamitsu Pharmaceuticals, Co., Inc.,
- Abbvie, Inc.,
- Valeant Pharmaceuticals,
- Antares Pharma
- Among others.
The global topical drug delivery market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals.
Other players in this market include Allergen Plc. Kaken Pharmaceuticals, Co., Ltd, Pfizer, 3M, Hisamitsu Pharmaceuticals, Co., Inc., Abbvie, Inc., Antares Pharma among others.
Some of the other players in the global topical drug delivery market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., and Solvay among others.
Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science.
- On July 2015, the U.S. Food and Drug Administration (FDA) approved Finacea Foam, for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
Valeant Pharmaceuticals International, Inc.
- Founded in 1994 and headquartered in Quebec, Canada, Valeant Pharmaceuticals International, Inc. is a pharmaceutical company which engages in developing, manufacturing, and marketing pharmaceutical products in the areas of dermatology, eye health, neurology, and generics.
In August 2016, Valeant announced the re-launch of its generic ofloxacin otic solution to treat bacterial ear infections. The product was temporarily discontinued in April 2015 due to an issue concerning the active pharmaceutical ingredient supplier, which has been resolved.
Read more about this Report at databridgemarketresearch.com/repor…-delivery-market/
Table of Content:
- RESEARCH METHODOLOGY
- MARKET LANDSCAPE SUMMARY
- PREMIUM INSIGHTS
- EXECUTIVE SUMMARY
- TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
- TOPICAL DRUG DELIVERY MARKET, BY END-USER
- TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
- TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
- TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE
- TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)
11.2. CRESCITA THERAPEUTICS
11.3. GALDERMA S.A.
11.4. BIOFARMITALIA S.R.L
11.5. PHARMATEK LABORATORIES, INC.
11.6. STIEFEL LABORATORIES, INC.
11.8. NITTO DENKO CORPORATION
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
11.9. MYLAN PHARMACEUTICALS INC.
11.9. HISAMITSU PHARMACEUTICAL CO., INC.
11.10. THERASOLVE NV.
11.11. SAMYANG BIOPHARMACEUTICALS CORPORATION
11.12. LOHMANN THERAPIE-SYSTEME AG
11.13. PROSOLLUS PHARMACEUTICALS
11.14. EASTON PHARMACEUTICALS INC.
11.15. ANTARES PHARMA, INC.
11.16. ENDO PHARMACEUTICALS INC.
11.17. TRANSDERMAL TECHNOLOGIES, INC.
11.18. SHEFFIELD PHARMACEUTICALS, INC.
11.20. 3M DRUG DELIVERY SYSTEMS
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: